Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.
暂无分享,去创建一个
Andrew J Copas | A. Copas | A. Grant | P. Walzer | Robert F Miller | Alison D Grant | Peter D Walzer | Hannah E R Evans | Simon G Edwards | S. Edwards | H. Evans
[1] P. Yarnold,et al. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era , 2001, Journal of General Internal Medicine.
[2] J. Chmiel,et al. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. , 2004, Chest.
[3] J. Singer,et al. Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia. , 1999, Archives of internal medicine.
[4] R. Miller,et al. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. , 1989, Thorax.
[5] B. Clotet,et al. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for european patients with acquired immunodeficiency syndrome , 1995 .
[6] R. Miller,et al. Bronchopulmonary Kaposi's sarcoma in patients with AIDS. , 1992, Thorax.
[7] J. Lundgren,et al. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. , 2001, Chest.
[8] A. Copas,et al. Climate and genotypes of Pneumocystis jirovecii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] L. Levin,et al. Antibody Response to Pneumocystis jirovecii , 2006, Emerging infectious diseases.
[10] R. Baughman,et al. Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. , 1992, Archives of internal medicine.
[11] H. Nagaraja,et al. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. , 1999, American journal of respiratory and critical care medicine.
[12] P. Kvale,et al. Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. , 2000, American journal of respiratory and critical care medicine.
[13] M. Segal,et al. Temporal trends and factors associated with survival after Pneumocystis carinii pneumonia in California, 1983-1992. , 1997, American journal of epidemiology.
[14] F. Ognibene,et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. , 1987, The American review of respiratory disease.
[15] J. Chmiel,et al. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. , 2000, American journal of respiratory and critical care medicine.
[16] J. Lundgren,et al. Independent risk of mechanical ventilation for AIDS-related Pneumocystis carinii pneumonia associated with bronchoalveolar lavage neutrophilia. , 2001, Respiratory medicine.
[17] Robert F Miller,et al. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients. , 2003, The Journal of infectious diseases.
[18] M. Singer,et al. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy , 2006, Thorax.
[19] J. Stringer,et al. Pneumocystis and Trypanosoma cruzi: Nomenclature and Typifications , 2006, The Journal of eukaryotic microbiology.
[20] C. Beard,et al. Current Epidemiology of Pneumocystis Pneumonia , 2004, Emerging infectious diseases.
[21] J. Schafer. Multiple imputation: a primer , 1999, Statistical methods in medical research.
[22] R. Wachter,et al. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. , 2002, American journal of respiratory and critical care medicine.
[23] L. Lutwick,et al. Pneumocystis carinii pneumonia in pregnancy. , 2001, Chest.
[24] R. Wachter,et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia , 2003, AIDS.
[25] T. Navin,et al. Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States. , 2001, The Journal of infectious diseases.
[26] P. Dickman,et al. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. , 1989, The American review of respiratory disease.
[27] J. Pulvirenti,et al. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era. , 2003, AIDS patient care and STDs.
[28] R. Rodríguez-Roisín,et al. Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS. , 1995, Thorax.
[29] F. Sciurba,et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. , 2004, American journal of respiratory and critical care medicine.
[30] R. Garland,et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. , 2000, Chest.
[31] E. Beck,et al. Hospital service interventions and improving survival of AIDS patients St Mary's Hospital, London, 1982-1991. , 1998, International journal of STD & AIDS.
[32] R. Weinstein,et al. Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. , 1995, American journal of respiratory and critical care medicine.
[33] C. Katlama,et al. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe. , 1995, Archives of internal medicine.
[34] P. Yarnold,et al. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. , 2000, American journal of respiratory and critical care medicine.
[35] N. Maskell,et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study , 2003, Thorax.
[36] J. Lundgren,et al. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia , 1999, The Lancet.
[37] H. Kessler,et al. Combined APACHE II score and serum lactate dehydrogenase as predictors of in-hospital mortality caused by first episode Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. , 1991, The American review of respiratory disease.
[38] B. Lüderitz,et al. Predicting in-hospital outcome in HIV-associatedPneumocystis carinii pneumonia , 1995, Infection.
[39] A. Limper,et al. Pneumocystis pneumonia. , 2004, The New England journal of medicine.